John G Ullman & Associates Inc Gsk PLC Transaction History

John G Ullman & Associates Inc

$649 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$42.05 - $47.77 $117,739 - $133,756	-2,800 Reduced 0.76%	367,382 $16 Million
Q1 2022 Apr 29, 2022	SELL	$40.23 - $47.74 $332,943 - $395,096	-8,276 Reduced 2.19%	370,182 $16.1 Million
Q4 2021 Jan 26, 2022	SELL	$38.88 - $45.31 $746,496 - $869,952	-19,200 Reduced 4.83%	378,458 $16.7 Million
Q3 2021 Nov 02, 2021	SELL	$38.79 - $43.16 $4.92 Million - $5.47 Million	-126,815 Reduced 24.18%	397,658 $15.2 Million
Q2 2021 Jul 23, 2021	SELL	$36.52 - $41.46 $135,124 - $153,402	-3,700 Reduced 0.7%	524,473 $20.9 Million
Q1 2021 Apr 22, 2021	BUY	$34.27 - $40.01 $4.06 Million - $4.74 Million	118,457 Added 28.91%	528,173 $18.9 Million
Q4 2020 Feb 05, 2021	BUY	$34.07 - $39.94 $59,588 - $69,855	1,749 Added 0.43%	409,716 $15.1 Million
Q3 2020 Nov 06, 2020	SELL	$38.11 - $42.99 $264,216 - $298,049	-6,933 Reduced 1.67%	407,967 $15.4 Million
Q2 2020 Jul 29, 2020	SELL	$37.87 - $43.58 $436,451 - $502,259	-11,525 Reduced 2.7%	414,900 $16.9 Million
Q1 2020 Apr 14, 2020	BUY	$32.47 - $48.83 $3.72 Million - $5.59 Million	114,550 Added 36.73%	426,425 $16.2 Million
Q4 2019 Jan 29, 2020	SELL	$42.0 - $48.25 $301,350 - $346,193	-7,175 Reduced 2.25%	311,875 $14.7 Million
Q3 2019 Oct 21, 2019	BUY	$40.46 - $43.52 $316,599 - $340,544	7,825 Added 2.51%	319,050 $13.6 Million
Q2 2019 Aug 02, 2019	BUY	$39.4 - $42.7 $2.55 Million - $2.76 Million	64,725 Added 26.26%	311,225 $12.5 Million
Q1 2019 Apr 30, 2019	BUY	$38.57 - $42.69 $1.77 Million - $1.96 Million	45,800 Added 22.82%	246,500 $10.3 Million
Q4 2018 Jan 29, 2019	BUY	$37.8 - $42.69 $3.52 Million - $3.98 Million	93,165 Added 86.64%	200,700 $7.67 Million
Q3 2018 Nov 02, 2018	BUY	$39.75 - $42.69 $1.4 Million - $1.5 Million	35,200 Added 48.66%	107,535 $4.32 Million
Q2 2018 Jul 23, 2018	SELL	$39.61 - $42.76 $150,518 - $162,488	-3,800 Reduced 4.99%	72,335 $2.92 Million
Q1 2018 Apr 19, 2018	BUY	$36.18 - $40.15 $143,815 - $159,596	3,975 Added 5.51%	76,135 $2.98 Million
Q4 2017 Jan 31, 2018	SELL	$35.34 - $41.9 $3.81 Million - $4.52 Million	-107,798 Reduced 59.9%	72,160 $2.56 Million
Q3 2017 Nov 03, 2017	BUY	$39.44 - $41.55 $7.1 Million - $7.48 Million	179,958	179,958 $7.31 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account